Literature DB >> 33371874

Deep learning detection of informative features in tau PET for Alzheimer's disease classification.

Taeho Jo1,2,3, Kwangsik Nho1,2,3, Shannon L Risacher1,2,3, Andrew J Saykin4,5,6.   

Abstract

BACKGROUND: Alzheimer's disease (AD) is the most common type of dementia, typically characterized by memory loss followed by progressive cognitive decline and functional impairment. Many clinical trials of potential therapies for AD have failed, and there is currently no approved disease-modifying treatment. Biomarkers for early detection and mechanistic understanding of disease course are critical for drug development and clinical trials. Amyloid has been the focus of most biomarker research. Here, we developed a deep learning-based framework to identify informative features for AD classification using tau positron emission tomography (PET) scans.
RESULTS: The 3D convolutional neural network (CNN)-based classification model of AD from cognitively normal (CN) yielded an average accuracy of 90.8% based on five-fold cross-validation. The LRP model identified the brain regions in tau PET images that contributed most to the AD classification from CN. The top identified regions included the hippocampus, parahippocampus, thalamus, and fusiform. The layer-wise relevance propagation (LRP) results were consistent with those from the voxel-wise analysis in SPM12, showing significant focal AD associated regional tau deposition in the bilateral temporal lobes including the entorhinal cortex. The AD probability scores calculated by the classifier were correlated with brain tau deposition in the medial temporal lobe in MCI participants (r = 0.43 for early MCI and r = 0.49 for late MCI).
CONCLUSION: A deep learning framework combining 3D CNN and LRP algorithms can be used with tau PET images to identify informative features for AD classification and may have application for early detection during prodromal stages of AD.

Entities:  

Keywords:  Alzheimer’s disease; Deep learning; Tau PET

Mesh:

Substances:

Year:  2020        PMID: 33371874      PMCID: PMC7768646          DOI: 10.1186/s12859-020-03848-0

Source DB:  PubMed          Journal:  BMC Bioinformatics        ISSN: 1471-2105            Impact factor:   3.169


  24 in total

Review 1.  A survey on deep learning in medical image analysis.

Authors:  Geert Litjens; Thijs Kooi; Babak Ehteshami Bejnordi; Arnaud Arindra Adiyoso Setio; Francesco Ciompi; Mohsen Ghafoorian; Jeroen A W M van der Laak; Bram van Ginneken; Clara I Sánchez
Journal:  Med Image Anal       Date:  2017-07-26       Impact factor: 8.545

Review 2.  Genetic studies of quantitative MCI and AD phenotypes in ADNI: Progress, opportunities, and plans.

Authors:  Andrew J Saykin; Li Shen; Xiaohui Yao; Sungeun Kim; Kwangsik Nho; Shannon L Risacher; Vijay K Ramanan; Tatiana M Foroud; Kelley M Faber; Nadeem Sarwar; Leanne M Munsie; Xiaolan Hu; Holly D Soares; Steven G Potkin; Paul M Thompson; John S K Kauwe; Rima Kaddurah-Daouk; Robert C Green; Arthur W Toga; Michael W Weiner
Journal:  Alzheimers Dement       Date:  2015-07       Impact factor: 21.566

Review 3.  Deep Learning in Medical Image Analysis.

Authors:  Dinggang Shen; Guorong Wu; Heung-Il Suk
Journal:  Annu Rev Biomed Eng       Date:  2017-03-09       Impact factor: 9.590

Review 4.  Tau imaging: early progress and future directions.

Authors:  Victor L Villemagne; Michelle T Fodero-Tavoletti; Colin L Masters; Christopher C Rowe
Journal:  Lancet Neurol       Date:  2015-01       Impact factor: 44.182

5.  PET Imaging of Tau Deposition in the Aging Human Brain.

Authors:  Michael Schöll; Samuel N Lockhart; Daniel R Schonhaut; James P O'Neil; Mustafa Janabi; Rik Ossenkoppele; Suzanne L Baker; Jacob W Vogel; Jamie Faria; Henry D Schwimmer; Gil D Rabinovici; William J Jagust
Journal:  Neuron       Date:  2016-03-02       Impact factor: 17.173

6.  Tau positron emission tomographic imaging in aging and early Alzheimer disease.

Authors:  Keith A Johnson; Aaron Schultz; Rebecca A Betensky; J Alex Becker; Jorge Sepulcre; Dorene Rentz; Elizabeth Mormino; Jasmeer Chhatwal; Rebecca Amariglio; Kate Papp; Gad Marshall; Mark Albers; Samantha Mauro; Lesley Pepin; Jonathan Alverio; Kelly Judge; Marlie Philiossaint; Timothy Shoup; Daniel Yokell; Bradford Dickerson; Teresa Gomez-Isla; Bradley Hyman; Neil Vasdev; Reisa Sperling
Journal:  Ann Neurol       Date:  2015-12-15       Impact factor: 10.422

7.  BRAIN NETWORKS. Correlated gene expression supports synchronous activity in brain networks.

Authors:  Jonas Richiardi; Andre Altmann; Anna-Clare Milazzo; Catie Chang; M Mallar Chakravarty; Tobias Banaschewski; Gareth J Barker; Arun L W Bokde; Uli Bromberg; Christian Büchel; Patricia Conrod; Mira Fauth-Bühler; Herta Flor; Vincent Frouin; Jürgen Gallinat; Hugh Garavan; Penny Gowland; Andreas Heinz; Hervé Lemaître; Karl F Mann; Jean-Luc Martinot; Frauke Nees; Tomáš Paus; Zdenka Pausova; Marcella Rietschel; Trevor W Robbins; Michael N Smolka; Rainer Spanagel; Andreas Ströhle; Gunter Schumann; Mike Hawrylycz; Jean-Baptiste Poline; Michael D Greicius
Journal:  Science       Date:  2015-06-11       Impact factor: 47.728

8.  On Pixel-Wise Explanations for Non-Linear Classifier Decisions by Layer-Wise Relevance Propagation.

Authors:  Sebastian Bach; Alexander Binder; Grégoire Montavon; Frederick Klauschen; Klaus-Robert Müller; Wojciech Samek
Journal:  PLoS One       Date:  2015-07-10       Impact factor: 3.240

9.  Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity.

Authors:  Sebastian Palmqvist; Michael Schöll; Olof Strandberg; Niklas Mattsson; Erik Stomrud; Henrik Zetterberg; Kaj Blennow; Susan Landau; William Jagust; Oskar Hansson
Journal:  Nat Commun       Date:  2017-10-31       Impact factor: 14.919

10.  Plasma amyloid beta levels are associated with cerebral amyloid and tau deposition.

Authors:  Shannon L Risacher; Noelia Fandos; Judith Romero; Ian Sherriff; Pedro Pesini; Andrew J Saykin; Liana G Apostolova
Journal:  Alzheimers Dement (Amst)       Date:  2019-07-26
View more
  8 in total

Review 1.  Application of artificial intelligence in brain molecular imaging.

Authors:  Satoshi Minoshima; Donna Cross
Journal:  Ann Nucl Med       Date:  2022-01-14       Impact factor: 2.668

2.  Deep learning-based identification of genetic variants: application to Alzheimer's disease classification.

Authors:  Taeho Jo; Kwangsik Nho; Paula Bice; Andrew J Saykin
Journal:  Brief Bioinform       Date:  2022-03-10       Impact factor: 11.622

Review 3.  Deep Learning-Based Diagnosis of Alzheimer's Disease.

Authors:  Tausifa Jan Saleem; Syed Rameem Zahra; Fan Wu; Ahmed Alwakeel; Mohammed Alwakeel; Fathe Jeribi; Mohammad Hijji
Journal:  J Pers Med       Date:  2022-05-18

4.  Deep learning improves utility of tau PET in the study of Alzheimer's disease.

Authors:  James Zou; David Park; Aubrey Johnson; Xinyang Feng; Michelle Pardo; Jeanelle France; Zeljko Tomljanovic; Adam M Brickman; Devangere P Devanand; José A Luchsinger; William C Kreisl; Frank A Provenzano
Journal:  Alzheimers Dement (Amst)       Date:  2021-12-31

Review 5.  The Road to Personalized Medicine in Alzheimer's Disease: The Use of Artificial Intelligence.

Authors:  Anuschka Silva-Spínola; Inês Baldeiras; Joel P Arrais; Isabel Santana
Journal:  Biomedicines       Date:  2022-01-29

6.  A multi-expert ensemble system for predicting Alzheimer transition using clinical features.

Authors:  Mario Merone; Sebastian Luca D'Addario; Pierandrea Mirino; Francesca Bertino; Cecilia Guariglia; Rossella Ventura; Adriano Capirchio; Gianluca Baldassarre; Massimo Silvetti; Daniele Caligiore
Journal:  Brain Inform       Date:  2022-09-03

7.  Diagnostic accuracy study of automated stratification of Alzheimer's disease and mild cognitive impairment via deep learning based on MRI.

Authors:  Xiaowen Chen; Mingyue Tang; Aimin Liu; Xiaoqin Wei
Journal:  Ann Transl Med       Date:  2022-07

8.  Machine Learning and Novel Biomarkers for the Diagnosis of Alzheimer's Disease.

Authors:  Chun-Hung Chang; Chieh-Hsin Lin; Hsien-Yuan Lane
Journal:  Int J Mol Sci       Date:  2021-03-09       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.